FewerJobs.

Korro Bio Inc jobs

7 matches, filter-driven and evidence-linked.

Reset
24 shown of 7

Benefit evidence

Resolvable source Inferred from posting Unknown provenance
Only verified benefits
  • Research Associate/Senior Research Associate, Oligonucleotide Chemistry

    Korro Bio Inc - 60 First St, Cambridge, MA 02141
    Indexed from Lever Benefit evidence checked Nov 20, 2026
    3w ago

    Why we showed this

    Description: "inc"Description: "korro"
    +6
    Unspecified Other - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reported

    Research Associate/Senior Research Associate, Oligonucleotide Chemistry 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human

  • Senior Clinical Trial Manager

    Korro Bio Inc - 60 First St, Cambridge, MA 02141
    Indexed from Lever Benefit evidence checked Nov 20, 2026
    posted 66 days ago

    Why we showed this

    Description: "korro"Description: "inc"
    +6
    Unspecified Healthcare From the posting source - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reported

    Senior Clinical Trial Manager 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health. Korro

  • Associate Director, Data Manager

    Korro Bio Inc - 60 First St, Cambridge, MA 02141
    Indexed from Lever Benefit evidence checked Nov 20, 2026
    posted 56 days ago

    Why we showed this

    Description: "korro"Description: "inc"
    +6
    Unspecified Other - Director Plus From the posting source Salary not disclosed Equity Inferred from posting 401(k) reported

    Associate Director, Data Manager 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health. Korro

  • Associate Director, Clinical Quality Assurance

    Korro Bio Inc - 60 First St, Cambridge, MA 02141
    Indexed from Lever Benefit evidence checked Nov 20, 2026
    posted 50 days ago

    Why we showed this

    Description: "korro"Description: "bio"
    +6
    Unspecified Healthcare From the posting source - Director Plus From the posting source Salary not disclosed Equity Inferred from posting 401(k) reported

    Associate Director, Clinical Quality Assurance 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.

  • Senior Manager, Contracts Management

    Korro Bio Inc - 60 First St, Cambridge, MA 02141
    Indexed from Lever Benefit evidence checked Nov 20, 2026
    3w ago

    Why we showed this

    Description: "korro"Description: "inc"
    +6
    Unspecified Other - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reported

    Senior Manager, Contracts Management 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health. Korro

  • Senior Scientist, High Throughput Screening

    Korro Bio Inc - 60 First St, Cambridge, MA 02141
    Indexed from Lever Benefit evidence checked Nov 20, 2026
    posted 50 days ago

    Why we showed this

    Description: "inc"Description: "bio"
    +6
    Unspecified Other - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reported

    Senior Scientist, High Throughput Screening 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.

  • Associate Medical Director / Medical Director

    Korro Bio Inc - 60 First St, Cambridge, MA 02141
    Indexed from Lever Benefit evidence checked Nov 20, 2026
    posted 42 days ago

    Why we showed this

    Description: "bio"Description: "inc"
    +6
    Unspecified Healthcare From the posting source - Director Plus From the posting source Salary not disclosed Equity Inferred from posting 401(k) reported

    Associate Medical Director / Medical Director 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human

  • People Operations Manager

    Formation Bio - New York, NY; Boston, MA
    Indexed from Greenhouse Comp disclosed in posting
    2w ago

    Why we showed this

    Description: "inc"Description: "bio"
    +3
    Unspecified Hr From the posting source - Mid From the posting source $122K-$155K From the posting source Equity

    People Operations Manager New York, NY; Boston, MA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As People Operations Manager at Formation Bio, you will own the day-to-day operations that support our employees throughout their

  • Combination Welder - Austin Industrial Decatur, IL BIO

    Austin Industries - Decatur, IL
    Indexed from Ukg Pro Benefit evidence checked Nov 20, 2026
    1w ago

    Why we showed this

    Description: "bio"Description: "inc"
    +3
    Unspecified Trades From the posting source - Mid From the posting source Salary not disclosed Inferred from posting 401(k) reported

    Combination Welder - Austin Industrial Decatur, IL BIO Decatur, IL Austin Industrial Inc. is currently seeking an experienced Combination Welder to be based in Decatur, IL This position is not offering per diem, 5-8's, $21.22-$39.33per hour BIO

  • Associate Director, Bioanalytical Development

    Formation Bio - Boston, MA; New York, NY
    Indexed from Greenhouse Comp disclosed in posting
    posted 262 days ago

    Why we showed this

    Description: "inc"Description: "bio"
    +4
    Unspecified Healthcare From the posting source - Director Plus From the posting source $178K-$232K From the posting source Equity

    Associate Director, Bioanalytical Development Boston, MA; New York, NY About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position The Associate Director, Bioanalytical will lead bioanalytical strategy and delivery for assigned programs, working across nonclinical and clinical

  • Millwright/Boilermaker Apprentice- Austin Industrial Decatur, IL BIO

    Austin Industries - Decatur, IL
    Indexed from Ukg Pro Benefit evidence checked Nov 20, 2026 Comp disclosed in posting
    1w ago

    Why we showed this

    Description: "bio"Description: "inc"
    +3
    Unspecified Trades From the posting source - Entry From the posting source $21.74-$37.26/hr From the posting source Inferred from posting 401(k) reported

    Millwright/Boilermaker Apprentice- Austin Industrial Decatur, IL BIO Decatur, IL Austin Industrial, Inc. - is currently seeking an experienced Millwright to be based in Decatur, IL This position is not offering per diem, 5-8's, $21.74-$37.26 per hour. BIO Tank experience a plus

  • Senior Software Engineer

    Formation Bio - New York, NY; Boston, MA; San Francisco, CA
    Indexed from Greenhouse Comp disclosed in posting
    posted 63 days ago

    Why we showed this

    Description: "bio"Description: "inc"
    +3
    Unspecified Engineering From the posting source - Senior From the posting source $186K-$232K From the posting source Equity

    Senior Software Engineer New York, NY; Boston, MA; San Francisco, CA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As a Senior Software Engineer at Formation Bio, you will build high-leverage software across the org.

  • Engineering Manager, Infrastructure

    Formation Bio - New York, NY; Boston, MA; San Francisco, CA
    Indexed from Greenhouse Comp disclosed in posting
    posted 81 days ago

    Why we showed this

    Description: "bio"Description: "inc"
    +3
    Unspecified Engineering From the posting source - Mid From the posting source $186K-$232K From the posting source Equity

    Engineering Manager, Infrastructure New York, NY; Boston, MA; San Francisco, CA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As the Engineering Manager for Infrastructure at Formation Bio, you will lead the team responsible for

  • Manager, Cybersecurity

    Formation Bio - New York, NY; Boston, MA
    Indexed from Greenhouse Comp disclosed in posting
    2w ago

    Why we showed this

    Description: "bio"Description: "inc"
    +3
    Unspecified Security From the posting source - Mid From the posting source $186K-$232K From the posting source Equity

    Manager, Cybersecurity New York, NY; Boston, MA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About this Role & Why it Matters You will lead security, reporting to the Director of Technical Operations and working closely with the

  • Business Development Operations Associate

    Formation Bio - Boston, MA; New York, NY
    Indexed from Greenhouse Comp disclosed in posting
    3w ago

    Why we showed this

    Description: "inc"Description: "bio"
    +3
    Unspecified Sales From the posting source - Entry From the posting source $106K-$132K From the posting source Equity

    Business Development Operations Associate Boston, MA; New York, NY About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position This role keeps Business Development (BD) running and makes it run better. You will own the recurring workflows

  • Associate Director, Data Engineering

    Formation Bio - New York, NY; Boston, MA; San Francisco, CA
    Indexed from Greenhouse Comp disclosed in posting
    posted 81 days ago

    Why we showed this

    Description: "bio"Description: "inc"
    +3
    Unspecified Other - Director Plus From the posting source $214K-$267K From the posting source Equity

    Associate Director, Data Engineering New York, NY; Boston, MA; San Francisco, CA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position Every decision at Formation Bio, from which drug asset to pursue to how a trial

  • Senior Site Reliability Engineer

    Formation Bio - New York, NY; Boston, MA; San Francisco, CA
    Indexed from Greenhouse Comp disclosed in posting
    posted 63 days ago

    Why we showed this

    Description: "inc"Description: "bio"
    +3
    Unspecified Engineering From the posting source - Senior From the posting source $186K-$232K From the posting source Equity

    Senior Site Reliability Engineer New York, NY; Boston, MA; San Francisco, CA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As a Senior Site Reliability Engineer at Formation Bio, you will build and operate the

  • Senior / Principal Technical Recruiter

    Formation Bio - New York, NY; Boston, MA
    Indexed from Greenhouse Comp disclosed in posting
    posted 119 days ago

    Why we showed this

    Description: "bio"Description: "inc"
    +4
    Unspecified Hr From the posting source - Principal From the posting source $154K-$202K From the posting source Equity

    Senior / Principal Technical Recruiter New York, NY; Boston, MA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. Why This Role Matters People are the single most important thing we have to get right to succeed as a

  • Senior Software Engineer II, Trial Engine

    Formation Bio - New York, NY; Boston, MA; San Francisco, CA
    Indexed from Greenhouse Comp disclosed in posting
    posted 81 days ago

    Why we showed this

    Description: "inc"Description: "bio"
    +3
    Unspecified Engineering From the posting source - Senior From the posting source $214K-$267K From the posting source Equity

    Senior Software Engineer II, Trial Engine New York, NY; Boston, MA; San Francisco, CA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position Clinical trials are where drug development actually gets slow and expensive. Sites take

  • Senior Data Engineer

    Formation Bio - New York, NY; Boston, MA; San Francisco, CA
    Indexed from Greenhouse Comp disclosed in posting
    posted 63 days ago

    Why we showed this

    Description: "bio"Description: "inc"
    +3
    Unspecified Data From the posting source - Senior From the posting source $186K-$232K From the posting source Equity

    Senior Data Engineer New York, NY; Boston, MA; San Francisco, CA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As a Senior Data Engineer at Formation Bio, you will build the trusted data systems that

  • Director/Senior Director, Product - Applied Data Science

    Formation Bio - New York, NY; Boston, MA
    Indexed from Greenhouse Comp disclosed in posting
    posted 91 days ago

    Why we showed this

    Description: "bio"Description: "inc"
    +3
    Unspecified Other - Director Plus From the posting source $245K-$307K From the posting source Equity

    Director/Senior Director, Product - Applied Data Science New York, NY; Boston, MA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position This role sits on Formation's Asset Acquisition & Diligence (AAD) team. In the course of

  • Associate Director / Director, GMP Quality

    Formation Bio - Boston, MA; New York, NY
    Indexed from Greenhouse Comp disclosed in posting
    posted 130 days ago

    Why we showed this

    Description: "bio"Description: "inc"
    +3
    Unspecified Other - Director Plus From the posting source $162K-$232K From the posting source Equity

    Associate Director / Director, GMP Quality Boston, MA; New York, NY About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position The Associate Director or Director, GMP Quality Assurance is responsible for ensuring that all GMP-regulated activities,

  • Senior Director of Asset Quality Assurance

    Formation Bio - Boston, MA; New York, NY
    Indexed from Greenhouse Comp disclosed in posting
    posted 168 days ago

    Why we showed this

    Description: "inc"Description: "bio"
    +3
    Unspecified Operations From the posting source - Director Plus From the posting source $178K-$232K From the posting source Equity

    Senior Director of Asset Quality Assurance Boston, MA; New York, NY About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position Formation Bio is an AI native Biotech company running drug development programs, and the Quality function

  • Director, Financial Reporting

    Formation Bio - New York, NY; Boston, MA
    Indexed from Greenhouse Comp disclosed in posting
    posted 91 days ago

    Why we showed this

    Description: "inc"Description: "bio"
    +3
    Unspecified Finance From the posting source - Director Plus From the posting source $186K-$232K From the posting source Equity

    Director, Financial Reporting New York, NY; Boston, MA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position Formation Bio is hiring a Director of Financial Reporting to lead financial reporting functions, prepare technical accounting analysis, lead

Take this list with you

Download the 7 matching jobs in any format - read offline, archive, or hand to an AI assistant with your resume to find the best fits.

Or email it to me instead

The AI-ready prompt is a pre-written question you can paste into Claude, ChatGPT, Gemini, or Perplexity along with your resume. We never see your resume; this happens in your AI client of choice.

AI agent reading directly? Same data lives at /api/jobs.json?q=Korro+Bio+Inc&quality=all. See /llms.txt and /api/openapi.json for the full schema.